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Abstract
The rat represents an important animal model that, in many respects, is superior to the mouse for dissecting behavioral,
cardiovascular and other physiological pathologies relevant to humans. Derivation of induced pluripotent stem cells from
rats (riPS) opens the opportunity for gene targeting in specific rat strains, as well as for the development of new protocols
for the treatment of different degenerative diseases. Here, we report an improved lentivirus-based hit-and-run riPS
derivation protocol that makes use of small inhibitors of MEK and GSK3. We demonstrate that the excision of proviruses
does not affect either the karyotype or the differentiation ability of these cells. We show that the established riPS cells are
readily amenable to genetic manipulations such as stable electroporation. Finally, we propose a genetic tool for an
improvement of riPS cell quality in culture. These data may prompt iPS cell-based gene targeting in rat as well as the
development of iPS cell-based therapies using disease models established in this species.
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Introduction
For more than a century the rat has been an important animal
model, which is superior in many respects to the mouse, for
example for behavioral, cardiovascular and other physiological
studies. Numerous inbred and outbred rat strains are used in
different fields of research, and transgenic technologies are well
developed in this species. However, until recently, gene targeting
was not available in rats because ES cell derivation from pre-
implantation rat embryos repeatedly failed [1,2,3]. This led to the
mouse being used as the sole animal model for ES-cell based gene
targeting techniques and for the establishment of tissue replace-
ment therapies. A recent breakthrough finally allowed this
problem to be overcome. It was shown that serum-free defined
culture medium (N2B27) in conjunction with inhibition of the
MEK (mitogen activated protein kinase)/ERK (extracellular signal
regulated kinases 1 and 2) pathway and glycogen synthase kinase-3
(GSK3) by the small synthetic drugs PD0325901 and
CHIR99021, respectively, in combination with activation of the
LIF/STAT3 pathway (N2B27+2i+LIF), are required and suffi-
cient to set and maintain the so-called ‘‘ground state’’ of
pluripotent stem cells [4]. This empirical observation allowed ES
cell line derivation from previously non-permissive mouse strains,
such as NOD mice [5,6] and ultimately, after 20 years of
unsuccessful attempts, from rats [7,8]. The established cell culture
conditions were also demonstrated to be beneficial for the
establishment and maintenance of pluripotent cells from various
species including rat and human [4,6,7,9,10].
Induced pluripotent stem (iPS) cells are derived from somatic
cells reprogrammed to the pluripotent state by the induced
expression of defined transcription factors, achieved for the first
time by the seminal work of Takahashi and Yamanaka [11]. This
new type of pluripotent cells has offered new exciting options in
regenerative medicine allowing the replacement of cells and
organs with the patient’s own cells thereby avoiding immunolog-
ical complications. In order to develop such technologies in
approved animal models, iPS cells were also generated from
rodents. Despite numerous papers published describing mouse iPS
cells, very few groups reported the derivation of iPS cells from rat
(riPS). Interestingly, whereas inhibition of GSK3 and MEK/ERK
pathway was found to be critical for the survival and maintenance
of pluripotency in riPS cells in some studies [8,12,13,14], the
derivation of riPS cells using classical serum- and LIF-containing
mouse ES medium was also reported [15].
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In this study we applied the four reprogramming factors [11] to
derive iPS cells from rat embryonic fibroblasts (REF) using
different cell culture conditions. We report an improved protocol
for the generation and maintenance of these cells using small
inhibitors of the MEK/ERK pathway and GSK3. In addition, we
present a method suitable for their genetic modification by stable
transfection and propose a genetic tool for an improvement of riPS
cell quality in culture.
Materials and Methods
Ethics statement
All animal procedures were performed according to the
guidelines for the humane use of laboratory animals, with
standards corresponding to those prescribed by the American
Physiological Society. The teratoma formation and riPS cell
injection into rat preimplantation embryos with subsequent
analysis of chimeric embryos were performed in the Institute of
Cytology strictly in agreement with the animal protection
legislation acts of the Russian Federation and was approved as
humane use of laboratory animals by the Institute’s Ethical Board.
The isolation of rat embryonic fibroblasts (REF) was performed
using naturally mated animals which were sacrificed using a UK
Home Office ’Schedule 19 procedure which does not require
specific ethical approval.
Plasmids and lentiviruses
To induce pluripotency lentiviruses (human immunodeficiency
virus (HIV)-based retroviruses), encoding pluripotency factors
Oct4, Sox2, cMyc, and Klf4 were generated. To this end full-size
cDNAs of corresponding genes were amplified by PCR from
reverse-transcribed mouse ES cell polyA RNA and cloned in place
of the EGFP gene (Figure S3A) within the lentiviral vector
LVTHM provided by Didier Trono [16]. 293T cells were
transfected with envelope-encoding pMD2G (5 mg), packaging
pCMV-dR8.74PAX2 (5 mg), and either Oct4-, Sox2-, Klf4-, or cMyc-
encoding LVTHM-based plasmids (20 mg) by calcium-phosphate
method. Lentiviruses in cell culture supernatant were collected and
processed as described elsewhere [16].
Thymidine kinase (TK) gene was PCR amplified from pKO-NTKV-
1907 (Stratagene) and cloned into p2A2Btk-luc plasmid [17] at
NcoI/XhoI sites, replacing the luc sequence. The iresPuro-polyA
cassette was subsequently cloned at XhoI/SpeI sites just
downstream of the TK gene of the resulting plasmid to obtain
the p2A2Btk-TKiresPuro vector (Figure S3B).
Cell culture
Unless specified, all cell culture products were from Invitrogen
(Darmstadt, Germany). Mouse and rat embryonic fibroblasts
(MEF and REF, respectively) were routinely maintained in high
glucose DMEM supplemented with 10% FBS (Sigma-Aldrich, St.
Louis, MO), 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM
L-glutamine, 1x non-essential amino acids, 50 mM b-mercapto-
ethanol. MEFs were inactivated by cultivation in cell culture
media supplemented with 10 mg/ml mitomycin C (Sigma-Aldrich)
for 2 hr. In reprogramming experiments 3 different media were
used. ES media: Knockout DMEM supplemented with 15% ES
cell-qualified fetal bovine serum (Sigma), 100 U/ml penicillin,
100 mg/ml streptomycin, 2 mM L-glutamine, 1x non-essential
amino acids, 50 mM b-mercaptoethanol. SR media: Knockout
DMEM supplemented with 20% KnockOut serum replacement,
100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-gluta-
mine, 1x non-essential amino acids, 50 mM b-mercaptoethanol.
N2B27 media: mixture 1:1 of N2-media (DMEM/F12
supplemented with 1x N2, 100 U/ml penicillin, 100 mg/ml
streptomycin, 0.005% BSA, 25 mM b-mercaptoethanol) and B27
media (NBM supplemented with 1x B27 (without RA), 100 U/ml
penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, 25 mM b-
mercaptoethanol). When indicated, media were supplemented
with 500 U/ml LIF (PAA, Pasching, Austria), 3 mM GSK3
inhibitor CHIR99021 (Axon, Groningen, Nitherlands), 1 mM
MEK inhibitor PD0325901 (Axon), 0.5 mM A-83-01 (Tocris
Bioscience, Missouri, USA).
Derivation of riPS cells
To isolate REFs naturally mated Fischer344 female rats were
checked for the presence of a vaginal plug and thereafter sacrificed
at day 14 of pregnancy (E14). Isolated embryos were freed from
head and visceral tissues, minced, subsequently trypsinized and
plated on tissue culture dishes (passage 0). REFs at passage 3 were
seeded at 1.56104 cells/cm2 in a 6-well plate and transduced
24 hrs later with the LVTHM-based Oct4, Sox2, Klf4, cMyc, and
EGFP lentiviruses (see above). Four days later cells were split onto
a 10 cm culture dish (Falcon), containing mitomycin-inactivated
MEFs and cultured in one of the three reprogramming media (see
above). After 10-12 days, riPS cell colonies were picked,
dissociated in TrypLE-express, and expanded on MEF-feeder
cells in the respective reprogramming medium.
Maintenance and electroporation of riPS cells
riPS cells were routinely maintained on mitomycin-treated
MEFs in N2B27+2i+LIF media. Cells grew as round, compact
colonies, which tended to detach after 2-3 days in culture. Cells
were routinely replated every 3–5 days using TrypLE-express.
Depending of the proportion of attached cells, riPS cells were
either trypsinized on the plate, or collected from the supernatant,
centrifuged, and dissociated in suspension. This procedure allowed
removal of dead feeder cells as well as differentiated riPS cells,
which were usually stably attached to the substrate. For stable
transfection, riPS cells were harvested with TrypLE-express, and
subsequently co-electroporated (56106 cells,, 240 V, 500 mF) with
25 mg of circular pMC-Cre (kindly provided by K. Rajewsky) and
linearized p2A2B-tk-TKiresPuro plasmids (7:1 molar ratio). Puro-
mycin (2 mg/ml) was added 48 hrs later for 3 days; clones were
picked 10 days after electroporation into 96-well plates and
genotyped by PCR, using primers specific for exogenous Oct4,
Klf4, Sox2, cMyc, and EGFP and for the 2A2B-tk-TKiresPuro cassette
(primer sequences are listed in the Table S3). Three subclones,
derivatives of the clone IIIB9 were chosen for further analysis. riPS
cells harboring the 2A2Btk-TKiresPuro cassette were occasionally
cultured in the presence of 1 mg/ml puromycin (usually for 3 days
every 4–5 passages).
riPS cell karyotyping
Six primary male riPS cell clones, selected by Y-chromosome-
specific PCR of genomic DNA, and three sub-clones after Cre-
mediated lentivirus excision, were subjected to karyotyping
procedure as follows. Exponentially growing riPS cells were
incubated for 1 hr with 5 mg/ml ethidium bromide, then for
1.5 hrs with 0.5 mg/ml colchicine. Cells were next harvested with
TrypLE and incubated for 20 min at 37uC in 0.075 M KCl
solution, fixed in methanol/acetic acid (3:1), placed on pre-wet
chilled microscope slides, air-dried, stained for 5 min either with
Giemsa stain or with 200 ng/ml 49,6-diamidino-2-phenylindole
(DAPI) in 2xSSC buffer. Slides were rinsed with 2xSSC and
distilled water, then embedded under coverslips into antifading
solution (Vector). DAPI-stained chromosomes were identified as
described elsewhere [18]. Giemsa-stained metaphase spreads
Fischer Rat iPS Cells
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(90–140) were used for chromosome counts and polyploid cells
determination. To identify chromosomes from 9 to 66 DAPI
stained metaphase plates were analyzed. From 9 to 40 metaphase
spreads were examined in clones containing from 30 to 50 percent
of polyploid cells. DAPI-stained metaphase spreads were analyzed
using the AxioPlan 2 Imaging microscope (Zeiss, Germany)
equipped with CCD camera (CV M300, JAI Corporation, Japan),
CHROMA filter sets and ISIS4 image-processing package of
MetaSysteme GmbH at the Center for Joint Ownership for
Microscopic Analysis SB RAS (ICG SB RAS, Novosibirsk).
Immunocytochemistry and alkaline phosphatase staining
Cells were fixed in 4% paraformaldehyde (Sigma) and stained
with antibodies against Oct4 (sc-5279, Santa Cruz Biotechnology
Inc), SSEA-1 (MC-480, Developmental Studies Iowa Hybridoma
Bank), Nanog (REC-RCAB0002P-F, COSMO BIO CO., Tokyo,
Japan), and neuronal class III b-Tubulin (TUJ1) (MMS-435P,
Covance), as described elsewhere [19]. Immunostained cells were
examined either on a fluorescent microscope Leica DM6000 with
5x, 10x, 20x, and 40x air objectives or a confocal Leica TCS SP5
microscope with 206 air and 636 oil immersion objectives. UV
(405 nm), Argon (488 nm) and HeNe (633 nm) lasers were used to
excite the fluorophores. Images were acquired using the Leica
TCS SP5 software. For the alkaline phosphatase (AP) staining,
cells were fixed with 4% paraformaldehyde, washed with Tris-
maleate buffer pH 9.0, and subsequently incubated for 30 minutes
in Tris-maleate buffer, 4 mM MgCl2, 0.4 mg/ml N-AS-MX
(Sigma), 1 mg/ml Fast Red TR Salt (Sigma). Once red colonies
were detected the reaction was stopped by removing colored
solution and adding PBS, pH 7.4.
Clonability assay
To evaluate the effect of different small molecules on
maintaining the self-renewal riPS cells were trypsinized into single
cells and seeded at the density of 50 cells/cm2 in a 6-well plate on
mitomycin-treated MEFs. Cells were cultured for 5 days in N2B27
media containing different combinations of inhibitors and
subsequently fixed and subjected to the AP staining. Each
condition was done in triplicate. The number of AP-positive
colonies for each condition were averaged from 3 wells to evaluate
the percentage of undifferentiated clones. To assess the viability
the total number of survived colonies per well was counted.
In vitro differentiation of riPS cells
The in vitro differentiation of riPS cells was carried out by the
‘‘hanging drop’’ method. riPS cells were dissociated by TrypLE
express, resuspended in N2B27 medium containing CHIR99021,
and plated in hanging drops (800 cells per 20 ml drop). Embryoid
bodies, formed in hanging drops were collected after 2 days in
10 ml of N2B27 (w/o CHIR99021) and additionally cultured for
four more days in low-adhesive bacterial Petri dishes. Medium was
changed every second day. After 6 days, embryoid bodies were
harvested and transferred onto Matrigel-coated dishes, approxi-
mately 10–12 embryoid bodies per 1-well of a 6-well plate in
N2B27 medium. 6–8 days later differentiated cells were either
fixed in 4% paraformaldehyde in PBS and analyzed further by
immunocytochemistry or used for the RNA extraction and
subsequent RT-PCR analysis.
Teratoma formation
riPS cell subclones H5 and G3, exponentially growing on
mitomycin-treated feeder layer in N2B27+2i+LIF medium, were
treated for 3 days with puromycin (1 mg/ml), harvested with
TrypLE express, resuspended in PBS and injected subcutaneously
into athymic RNU rats (52106106 cells) or CD-1 NUDE mice
(1226106). After 6–8 weeks teratomas were removed from
euthanized animals and processed for histological analysis.
RiPS cell injection into rat preimplantation embryos
riPS cells (subclone H5) were trypsinized, resuspended in a small
amount of N2B27 medium and kept on ice until the injection.
Embryos were recovered by flushing the excised oviducts and
uterine horns with M2 medium (Sigma) from 2–5 months old
naturally mated female Sprague-Dawley-Hannover (SD) outbred
rats (Janvier, France) at day 4 post coitum, as previously described
[20,21]. 5–7 riPS cells were injected into 8 cell-stage embryos
placed in a drop of M2-medium under mineral oil. Immediately
after microinjection embryos were transferred into uterine horns of
anesthetized pseudopregnant (day 4 post coitum) SD females (10–
12 embryos per recipient) [20]. To examine the development of
fetuses and to recover live pups the recipient rats were euthanized
on day 18 of gestation. DNA was isolated for PCR analysis from
multiple embryonic tissues, including the tail, liver, kidney, heart,
and head, and also from extraembryonic tissue (placenta).
Subclone H5, used in this approach, harbors the 2A2Btk-TKiresPuro
cassette in its genome. A primer pair specific for this cassette was
used to distinguish between incorporated H5 riPS cells and host
embryo cells (primer sequences are listed in the Table S3). The
same primer pair and primers specific for the rat angiotensinogen
(AOGEN) gene (as an endogenous control) were used for the
evaluation of % chimerism in E18 fetuses by real time PCR (see
below). Standard curve was calculated by mixing H5 cells
(containing 2A2Btk-TKiresPuro cassette) and genetically unmodified
rat cells (WT) at different ratios: H5 only, H5:WT 1:4, 2:3, 3:2,
1:4, WT alone. H5 alone was taken as 100%. Real time PCR was
performed in technical duplicate.
Fluorescence-activated cell sorting (FACS) and real-time
PCR
For cytometric analysis 107–108 riPS IIIB9 cells (p22–p24) were
harvested with TrypLE-express, washed with PBS, and subse-
quently resuspended in 100 ml of PBS. Probes were sorted by flow
cytometry on FACSAria2 (BD Biosciences). 105 GFP-positive and
GFP-negative cells were plated to 6-well plates and GFP
fluorescence was monitored over 5 days in culture. Cells were
examined under a fluorescent microscope before plating to
exclude the presence of green cells in the GFP-negative
population. The rest of sorted cells were used for RNA
preparation. For RT and real time PCR analysis RNAs were
extracted by RNA mini kit (Qiagen). Residual genomic DNA was
removed by DNase I treatment (Qiagen). RNA was reverse
transcribed using random hexamers and Moloney murine
leukemia virus reverse transcriptase (M-MLV, Invitrogen). The
real-time PCR approach used the SYBR green reagent and a iQ5
BioRad cycler as described [19]. An established method was
applied to compare gene expression levels between groups, using
the equation 22DDCT [22]. Gene expression was normalized to
Nat1 mRNA expression. The primers used are listed in Table S3.
Real time PCR was run in technical duplicate.
Results and Discussion
To derive rat iPS (riPS) cells, rat embryonic fibroblasts (REFs)
were transduced with Oct4, Sox2, Klf4, cMyc and, for visualization,
with EGFP-encoding lentiviruses (OKSM+G) and then plated at a
low density on mitomycin-inactivated mouse embryonic fibroblasts
(MEF) feeder layer in media permissive for the propagation of iPS
Fischer Rat iPS Cells
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cells. In the first set of experiments we applied the original cell
culture conditions, described for mouse iPS cell derivation [11]
using serum- and LIF-containing medium. However, in contrast to
previously reported success in riPS cell derivation using similar
transduction and cell culture systems [15], this approach did not
result in any viable riPS cell colonies (Table 1).
Taking into account the recent success in the generation of rat ES
cells [7,8], we then applied the N2B27+2i+LIF culture conditions
and achieved a robust derivation of riPS cells from REFs with the
help of (OKSM+G) lentiviral vectors (Table 1, Figure 1A, Figure
S3A). The inclusion of the cMyc virus, although beneficial for the
efficiency of riPS cell derivation, was not obligatory (data not
shown). We next compared the N2B27+2i+LIF with previously
reported most efficient riPS cell-derivation medium containing
serum replacement (SR), sameMEK and GSK3 inhibitors (2i), LIF,
and additionally, the activin receptor-like kinase (ALK5) inhibitor
A-83-01 [14]. The numbers of primary riPS cell colonies were
slightly higher in the SR-based medium, however, the percentage of
surviving clones following 2 subsequent passages was 71% in the
N2B27-based vs. 25% in the SR-based medium, respectively
(Table 1).
Upon derivation eight individually picked clones, repro-
grammed in N2B27+2i+LIF conditions were propagated to
establish riPS cell lines. Cells were routinely maintained on
inactivated MEFs in N2B27+2i+LIF medium. Rat iPS cells
typically grew as compact clumps that tended to detach from
Table 1. Efficiencies of riPS cell derivation in different culture conditions.
Reprogramming Medium References
Reprogramming
efficiency
Total N of
picked clones
Total N of survived
clones
Survival rate after
2 passages
1 DMEM + 15% FCS +LIF [11,15] 0 0
2 DMEM + SR +2i + LIF + A-83-01 [14] 8.961.361024 48 37 25.0612.5%
3 N2B27 +2i + LIF [7] 5.46 0.961024* 48 12 70.866.3%*
To derive rat iPS (riPS) cells 1.56105 REFs were transduced with the LVTHM-based Oct4, Sox2, Klf4, cMyc, and EGFP lentiviruses. Four days later cells were split onto a
10 cm culture dish and cultured in one of the three reprogramming media. After 10–12 days, primary riPS cell colonies were counted to calculate the reprogramming
efficiency. Survival rate was calculated as a relation between the number of picked and the number of surviving clones after 2 passages.
*p,0.05, Student’s t-test condition 3 vs condition 2, [DMEM + SR +2i + LIF + A-83-01] N = 3; [N2B27+2i + LIF]: N = 4 independent experiments.
doi:10.1371/journal.pone.0027345.t001
Figure 1. Generation of rat iPS (riPS) cells. (A) Rat embryonic fibroblasts (REFs) (left), primary riPS cell colony derived thereof after transduction
with lentiviruses expressing Oct4, Klf4, Sox2, cMyc, and EGFP with some satellite colonies (middle), and riPS cell line after several passages in
N2B27+LIF+2i medium (right). (B) Karyotyping results of the G4 riPS cell clone, in which 90% of metaphase plates showed the normal male
chromosomal content (42,XY). (C) Cre-mediated excision of the proviruses in riPS cell clones H5, G3, and G4 from the genome of the parental IIIB9
riPS cell clone, shown by PCR of genomic DNA with primers specific for exogenous Oct4, Klf4, Sox2, cMyc, and EGFP sequences. PCR for the Y-
chromosome specific gene Sry confirmed the DNA integrity and male origin of riPS clone IIIB9. (D) Cre-mediated excision of EGFP-lentivirus visualized
in G3 riPS cell clone under fluorescent microscope.
doi:10.1371/journal.pone.0027345.g001
Fischer Rat iPS Cells
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substrate as colonies expanded, resembling in this respect rat ES
cells [8]. However, after rounds of trypsinization and passaging,
riPS cells changed their morphology, and flat and more adhesive
colonies appeared. These features make riPS cells notably different
from those of mouse origin. Also noticeable, primary riPS cell
colonies were frequently surrounded by small satellite colonies
(Figure 1A, central panel). With respect to these unusual
morphological characteristics, it would be of interest to compare,
for example, properties and expression levels of matrix adhesion
molecules in iPS and ES cells of both species.
Immunostaining for the pluripotency markers revealed that riPS
cells are positive for Oct4, Nanog, SSEA1 and alkaline
phosphatase (Figure 2A and Figure S4 A–C). Interestingly, despite
the presence of inhibitors which were shown to have a beneficial
effect on Nanog expression in mouse ES cells [23], in analysed
riPS cell lines Nanog showed a variable expression pattern,
consistent with previous observations in mouse ES cells grown in
serum-containing medium [24]. Further analysis showed that riPS
cells were able to form embryoid bodies and give rise to derivatives
of all three germ layers in course of in vitro differentiation (Figure
S4D). The clonability assay showed that riPS cell proliferation and
survival were severely compromised in the absence of GSK3
inhibitor CHIR99021, whereas omission of PD0325901 and LIF
from the culture medium led to the quick differentiation of riPS
cells (Table S1; Figure S2). Such a tight dependence upon the two
inhibitors and LIF during the derivation and maintenance
indicates that the newly obtained riPS cells are in the ground
state of pluripotency [4,7].
Because male ES cells are strongly preferred for gene targeting
in mouse, we reasoned that the same would apply to the rat iPS
cells. Thus we determined gender of primary riPS cell clones by
PCR with Sry-specific primers (Table S3 and data not shown). Six
selected clones were further karyotyped as shown in Figure 1B and
Table 2. All, except IIIA10, which is likely to be a mixed clone,
were confirmed to be XY. A characteristic of all six clones was a
high ratio of tetraploid and aneuploid cells (Table 2). The latter
cells were predominantly hypoploid with different chromosomes
being lost (data not shown). The clone that demonstrated the
highest ratio of cells with normal karyotype (IIIB9) was used for
subsequent manipulations. Of note, chromosomal instability
appears to be a hallmark of cultured ES cells. A recent study
reported an amplification of centrosomes, leading to both
polyploidization and aneuploidization of human ES cells [25].
Extensive analysis of 540 mouse ES cell lines showed that only
60% possess a normal diploid karyotype and 25% show a loss of
the X chromosome [26]. Significant chromosomal instability was
also reported for mouse and human iPS cells [11,27,28]. The rate
of chromosomal abnormalities may be a consequence of both
culture conditions and intrinsic properties of pluripotent cell lines.
It is also possible that chromosomal instability is a consequence of
the dramatic change in epigenetic state of cells during reprogram-
ming.
Although HIV-derived lentiviruses are considered to efficiently
resist epigenetic silencing in the majority of cell types, this is clearly
not the case with riPS cells. For example, we observed a high rate
of EGFP-encoding lentivirus silencing in newly derived riPS cell
clones, which became increasingly obvious with increasing
number of passages (Figure S1A–C). The same phenomenon has
also been observed in human iPS cells by others [14]. Interestingly,
while the silencing appeared in undifferentiated cells, reactivation
of lentiviral expression was observed in some spontaneously
differentiated cells (Figure S1D, E). Reset of the expression of
either Oct4, Sox2, or Klf4 in a subset of riPS cells might have an
adverse effect on their further differentiation to specific cell types,
Figure 2. Pluripotency of generated riPS cells. (A) Immunostain-
ing of cultured riPS cells for Nanog (left) (63x objective, confocal
imaging, clone IVC2), Oct4 (middle, clone IIIB9), and SSEA1 (right, clone
G4) (20x objective, fluorescent microscope). (B) RT-PCR analysis of gene
expression in undifferentiated riPS cells (clone H5) and in cells during
the course of in vitro differentiation via the embryoid body (EB) protocol
after 2 days (EB2), 6 days (EB6) and 12 days (dpp6, 6 days post plating)
of differentiation; shown is the analysis of mesodermal (AFP, Flk1),
endodermal (Gata4 and Sox17), and ectodermal marker (Nestin)
expression. (C) Differentiation of riPS cells into neurons in vitro, shown
by immunostaining with Tuj1 antibodies at dpp6 of differentiation
(clone H5). (D) H&E staining of sections of teratomas formed after a
subcutaneous injection of riPS cells (clone G3) into NUDE rats; shown
are stratified epithelium (left), cartilage (middle), and epithelium, likely
of endodermal origin (right), belonging to ectodermal, mesodermal,
and endodermal germ layers, respectively. (E) riPS cells (clone H5)
injected into 8-cell rat embryos can contribute to the formation of the
embryo proper and only to a very limited extend to the placenta, as
shown by PCR analysis of day 18 rat embryo DNA. H5 – riPS cell clone
used for the injection, 12 and 13 – positive and negative fetuses,
respectively. T – tail, L – liver, H – head, K – kidney, P – placenta.
doi:10.1371/journal.pone.0027345.g002
Fischer Rat iPS Cells
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27345
whereas reactivation of the cMyc provirus after its germline
transmission has been reported to induce tumor growth [29,30].
Therefore, we set out to delete the proviruses from the genome of
the reprogrammed cells, making use of the loxP sites included in
the proviral LTRs [16]. To this end, the riPS cell clone IIIB9,
chosen on the basis of the highest ratio of cells with normal
karyotype (Table 2), was co-electroporated with Cre recombinase-
encoding pMC-Cre plasmid and linearized p2A2Btk-TKiresPuro
plasmid. The latter, besides being useful for an enrichment of
Cre-electroporated cells via a rapid puromycin selection, resulted
in a dramatic improvement in the quality of riPS cell cultures (see
below). Provirus excision was monitored by PCR with primers
specific to exogenous (lentivirus-encoded) Oct4, Sox2, Klf4, cMyc,
and EGFP sequences (Figure 1C, D and Table S3). Out of 96
analyzed riPS cell subclones two (G4 and H5) were found to have
all 5 proviruses excised (Figure 1C, D, Table S2). The analyzed
subclones showed modal 42,XY karyotype (Table 2 and Figure 1B)
and were able to maintain iPS cell morphology and expression of
the pluripotency markers, (Fig. 2A and data not shown). Secondly,
the riPS cell subclones were able to differentiate in vitro by
formation of embryoid bodies (Figure 2B, C). Analysis of in vitro
differentiation ability showed that the procedure is much more
demanding in comparison to mouse iPS cells. Either the use of
serum-containing medium or the formation of aggregates from
single cell suspension in non-adherent dishes in serum-free
conditions both led to massive cell death at day 3–5 of
differentiation (data not shown). The hanging drop method using
serum-free medium supplemented with the GSK3 inhibitor
CHIR99021 during the first 2 days of differentiation, similar to
the approach reported for the rat ES cells [8], allowed us to
address the riPS cell viability issue. Thirdly, when injected into the
immune-compromised NUDE rats or mice, the riPS cell subclones
formed teratomas consisting of cell types derived from all three
germ layers (Figure 2D). Lastly, riPS cell subclones could
efficiently participate in embryonic development following their
injection into rat preimplantation embryos (Figure 2E). Out of 11
fetuses analyzed one showed a significant degree (,20%) of
chimerism (Table S4). Significant incorporation of differentiated
riPS cell descendants into tail, head, liver and kidney was tracked
by PCR of genomic DNA using primers specific for the 2A2Btk-
TKiresPuro cassette (Figure 2E, Figure S3B). In contrast, very
limited contribution to the placenta was detected (Figure 2E),
suggesting that riPS cells, like iPS and ES cells of other species,
lack the ability to differentiate into the trophoblast cell lineage.
Taken together, our data suggest that the newly derived cell lines
represent bona fide iPS cells and that Cre recombinase-mediated
excision does not produce any obvious chromosomal rearrange-
ments or loss of pluripotency.
Despite of the presence of LIF and both small inhibitors, riPS
cells showed some predisposition to spontaneous differentiation in
vitro and could be maintained in an undifferentiated state without
subcloning only for a limited number of passages. To address this
issue, we have developed a transgenic cassette that allowed a
selective and efficient elimination of differentiated cells in riPS cell
cultures. The 200-bp 2A2B sequence from the distal enhancer of
Pou5f1 (Oct4) gene, containing binding sites for Oct4 and Sox2
heterodimers (2B) and a DNA binding element of an unknown
transcription factor (2A), has been shown to act synergistically in
transient transfection as an ES cell-specific enhancer when
coupled to either the homologous Pou5f1 or to a heterologous
minimal promoter such as thymidine kinase (tk) [17]. Our data
suggests that the 2A2Btk enhancer/promoter moiety can direct
pluripotency-specific expression of transgenes not only transiently,
but also when stably delivered to the genome of ES and iPS cells
(data not shown). Making use of this property, we placed a two-
way selection bicistronic cassette (TKiresPuro) under transcriptional
control of 2A2Btk (Figure S3B) and stably delivered the resulting
construct into the genome of riPS cells via electroporation. This
manipulation, performed in parallel with the transient delivery of
Cre recombinase, allowed us to reliably improve, through brief
courses of puromycin selection, the quality of riPS cell cultures via
an efficient elimination of spontaneously arising differentiated cells
(Figure 3). Of note, we found this cassette functioning equally well
in mouse iPS cells, as well as in ES cells of both species (data not
shown). The cassette also facilitated enrichment for differentiated
cells in vitro (via the TK gene, data not shown). To our knowledge,
the 2A2Btk moiety represents the shortest known regulatory
element sensitive to the differentiation status of ES and iPS cells.
In addition, the relatively small size of this cassette allows stable
genome integration via lentiviral vectors (data not shown).
We have reported in this paper an optimized approach for the
derivation of riPS cells which makes use of various previously
reported improvements of iPS/ES-related methods. While com-
parable in term of derivation efficiency, our approach offers a
better survivability of picked riPS cell clones after subsequent
culturing, compared to the previously published non-excisable
lentivirus-based serum-free system [14]. Contrary to yet another
report [15], we failed to generate any viable riPS cells using serum-
containing culture medium, even with serum, which was well
permissive, for instance, for mouse iPS cell derivation (data not
Table 2. Summary of karyotype analysis of established riPS cell lines.
riPS cell clone/subclone Karyotytes in diploid cells % of diploid metaphase % of aneuploid metaphase % of polyploidy metaphase
IVF3 42,XY 60 17 23
IVF2 42,XY 50 50 N/A
IVC2 42,XY 68 9 23
IIIA10 42,XY/42XX 45 27 28
IVG3 42,XY 25 25 50
IIIB9 42,XY 79 1 20
G3* 42,XY 58 36 6
G4* 42,XY 90 6 4
H5* 42,XY 63 58 8
*Subclones of IIIB9 following Cre-mediated lentivirus excision.
doi:10.1371/journal.pone.0027345.t002
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shown). Thus our data emphasize the importance of using serum-
free medium for consistent results with riPS cell derivation. During
the time course of our studies another group reported a riPS cell
derivation protocol that used both REFs and rat neural precursors
as starting cell types and relied on serum-containing medium, non-
excisable moloney murine leukemia virus (MMLV)-based delivery
(in combination with ES cell extracts), and mitotically inactivated
REFs as feeder cell layer [13]. A direct comparison of this and our
method is not feasible. However, our approach seems to offer
several advantages: (1) well-known superior reprogramming
capacity of HIV-based, compared to MMLV-based retroviral
vectors; (2) a true hit-and-run strategy involving lentivirus excision
from the rat genome (without any obvious chromosomal
rearrangements) and, thus, the elimination of the risks associated
with reprogramming factor re-activation and, as a subsequence,
altered differentiation properties of riPS cells; (3) the approach as it
has been discussed above, eliminates the dependence on serum
batch variation. Recently proposed virus-free iPS derivation
systems [31,32,33,34,35] remain to be tested in the rat, however,
for the time being, the hit-and-run protocol offered in this paper
appears to be the most efficient and consistent.
Despite rapid progress in the development of novel genomic
technologies, such as RNA interference [36] and zinc-finger
nuclease technologies [37], gene targeting via homologous
recombination in ES cells currently remains the most straightfor-
ward approach in functional genomics. This approach, however,
has not been available for rat until recently, when rat ES cells have
been established [7,8], and subsequently shown to be amenable to
homologous recombination [10,38]. In this regard, riPS cells may
represent a viable alternative to rat ES cells for functional genetics
because their derivation, as shown in this and other studies, is
rather simple and straightforward and does not require a supply of
preimplantation embryos which can be a quite limited for some
strains of rat [[39] and E.P., unpublished data], relying instead on
easily preserved stocks of rat embryonic fibroblasts. In particular,
riPS cells can be isolated from the plethora of existing inbred rat
models for polygenic diseases [40], such as hypertension, diabetes
or epilepsy, and used to elucidate the pathogenetic mechanisms
involved in these disorders. Compared to ES cells, riPS cells are
preferable for the development of tissue replacement therapies,
allowing the isolation of recipient-specific pluripotent cells and
overcoming the problem of post-transplantation rejection. Lastly,
due to the fact that, to date, models of many human degenerative
diseases have been established solely in the rat, riPS cells represent
a very attractive tool for the validation of therapeutical
applications of iPS cell technologies in preclinical studies.
Supporting Information
Figure S1 Lentivirus silencing in undifferentiated riPS
cells. (A) riPS cell clone IIIB9 after 22 passages (p22) in culture.
Notice round compact, morphologically undifferentiated colonies
that have lost EGFP expression. (B) FACS for EGFP+ cells of riPS
cell clone IIIB9 p22 (lower panel) and its subclone IIIB9-G3
derived following the excision of proviruses, including EGPF. The
latter served as a negative control (upper panel). Similar results
were obtained in 2 independent experiments. (C) Real time PCR
analysis of sorted cells, showing that EGFP— riPS cells express
high levels of Nanog, confirming the pluripotent state of this cell
population. IIIB9: N=3; EGFP— , EGFP+: N= 2. (D) The
EGFP— fraction of riPS cells after FACS shows the onset of EGFP
expression in some cells already after 1 day in culture. (E) EGFP—
fraction cultured for further 4 days shows a substantial number of
EGFP+ cells. Note, that most of Oct4+ cells do not express EGFP,
whereas some of morphologically differentiated cells became
green.
(DOC)
Figure S2 RiPS cell clonability assay. Representative
images of alkaline phosphatase staining of riPS cells, seeded at a
density of 500 cells per well of a 6-well plate and cultured for 5
days in the presence of LIF and 2i (A, B), or in the presence of LIF
and CHIR99021 (C, D). 2.5x magnification (A, C). Examples of
an undifferentiated colony (B) and of a morphologically differen-
tiated colony with weak AP-staining (D) (20x and 10x magnifica-
tion, respectively). Similar results were obtained in 2 independent
experiments.
(DOC)
Figure S3 Plasmids and lentiviruses. (A) Map of the
lentiviral vectors used in this study. Oct4, Sox2, Klf4, and cMyc
cDNAs were cloned in place of the EGFP cDNA of the LVTHM
vector, which is described in greater details in elsewhere
(Wiznerowicz and Trono, 2003, J. Virol 77:8957-61). During
reverse transcription, the U3 region of the 59 LTR is synthesized
by using its 39 homologue as a template, which results in a
duplication of LoxP site in the provirus integrated in the genome
of transduced cells. The part of LV DNA between the loxP sites is
subject to Cre-mediated excision. LTR, cPPT, and WPRE are
lentiviral elements required for its integration and expression. (B)
Scheme of the 2A2Btk-TKiresPuro cassette (see text for abbrevia-
tions). Arrows indicate primers which were used to detect the
cassette in the riPS cell transfected clones. The same primer pair
was employed for the evaluation of % chimerism after injection of
riPS H5 cells into rat preimplantation embryos (Figure 2E and
Table S4).
(DOC)
Figure S4 Pluripotency of riPS cells. Expression of the
pluripotency markers Oct4, Nanog, and SSEA-1 in the primary
riPS cell clones IVB3 (A) and IVF3 (B) (passage 13), shown by
immuncytochemical staining with respective antibodies. (C)
Figure 3. Positive selection of undifferentiated riPS cells in
vitro. riPS cells (here clone H5) harboring the 2A2Btk-TKiresPuro
transgenic cassette show an increasing percentage of spontaneously
differentiated cells with flat morphology and reduced alkaline
phosphatase (AP) expression with increasing number of passages in
N2B27+2i+LIF medium (left column), whereas the differentiated cells
have been mostly eliminated from the culture following a 3-day
selection in the same culture medium containing 1 mg/ml puromycin
(right column). PH – phase contrast.
doi:10.1371/journal.pone.0027345.g003
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Alkaline phosphatase staining in the same two clones. (D) RT-
PCR analysis of pluripotency (Nanog), ectoderm (NCAM),
mesoderm (FLK and AFP), and endoderm (Sox17 and GATA4)
lineage marker expression during the time course of differentiation
of the same riPS cell clones using embryoid body (EB) protocols.
Cells were harvested at the indicated days after the EB formation
(D0-D10). Nat1 served as an endogenous mRNA control. NC-
negative control.
(DOC)
Table S1 LIF and inhibition of GSK3 and MEK1/ERK
signaling are essential for the riPS cell self-renewal. Cells
were seeded at a density of 50 cells/cm2 in a 6-well plate and
cultured in different conditions for 5 days. Total number of
surviving colonies, number of undifferentiated (AP-positive)
colonies and number of morphologically differentiated colonies
with partial AP-staining, which appeared specifically in the
absence of PD0325901 (see Figure S2C, D) were counted.
*p,0.01, **p,0.001 vs CHIR99021 + PD0325901 + LIF
condition (one way ANOVA with Bonferroni’s post test, N= 3
per condition. Similar results were obtained in 2 independent
experiments.
(DOC)
Table S2 Summary of subclones derived from riPS cell
clone IIIB9 after Cre-mediated excision of proviruses
and co-electroporation with p2A2Btk-TKiresPuro cas-
sette.
(DOC)
Table S3 List of primer pairs used in this study.
(DOC)
Table S4 Real time PCR analysis of E18 chimeric
embryos. RiPS cells, harboring 2A2Btk-TKiresPuro cassette in
their genome (clone H5) were injected into 8-cell rat embryos.
DNA isolated from fetuses at E18 was analyzed by real time PCR
using a primer pair specific for the 2A2Btk-TKiresPuro cassette
(Table S3 and Figure S3B) normalized to the rat angiotensinogen
(AOGEN) gene (this gene is present in both host embryo and
incorporated riPS cells). H5 – riPS cell clone used for the injection,
12 – positive E18 fetus. T – tail, L – liver, H – head, K – kidney,
P – placenta.
(DOC)
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